Presentation is loading. Please wait.

Presentation is loading. Please wait.

Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy—Challenges to Measuring Impact.

Similar presentations


Presentation on theme: "Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy—Challenges to Measuring Impact."— Presentation transcript:

1 Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy—Challenges to Measuring Impact and Change in Institutional Culture  Brandon P. Verdoorn, MD, Angela J. Luckhardt, RN, CNS, Sara E. Wordingham, MD, Shannon M. Dunlay, MD, MS, Keith M. Swetz, MD, MA  Journal of Pain and Symptom Management  Volume 54, Issue 2, Pages (August 2017) DOI: /j.jpainsymman Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions

2 Fig. 1 Survival, outcomes, and hospice utilization. DT = destination therapy; LVAD = left ventricular assist devices. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions


Download ppt "Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy—Challenges to Measuring Impact."

Similar presentations


Ads by Google